These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4635504)

  • 1. Respiratory diseases in cyclophosphamide-treated mice. I. Increased virulence of Mycoplasma pulmonis.
    Singer SH; Ford M; Kirschstein RL
    Infect Immun; 1972 Jun; 5(6):953-6. PubMed ID: 4635504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory diseases in cyclophosphamide-treated mice. II. Decreased virulence of PR8 influenza virus.
    Singer SH; Noguchi P; Kirschstein RL
    Infect Immun; 1972 Jun; 5(6):957-60. PubMed ID: 4635505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immunosuppression on arthritis in mice induced by Mycoplasma pulmonis.
    Taylor G; Taylor-Robinson D; Slavin G
    Ann Rheum Dis; 1974 Jul; 33(4):376-84. PubMed ID: 4547195
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors in resistance to and recovery from M. pulmonis-induced arthritis in mice.
    Taylor G; Taylor-Robinson D
    Ann Rheum Dis; 1977 Jun; 36(3):232-8. PubMed ID: 879860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of vaccines on Mycoplasma pulmonis-induced respiratory disease of mice.
    Taylor G; Howard CJ; Gourlay RN
    Infect Immun; 1977 May; 16(2):422-31. PubMed ID: 558962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of viral and mycoplasmal infections, ammonia exposure, vitamin A deficiency, host age, and organism strain on adherence of Mycoplasma pulmonis in cultured rat tracheas.
    Schoeb TR; Juliana MM; Nichols PW; Davis JK; Lindsey JR
    Lab Anim Sci; 1993 Oct; 43(5):417-24. PubMed ID: 8277719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal inoculation of Mycoplasma pulmonis in mice with severe combined immunodeficiency (SCID) causes a wasting disease with grave arthritis.
    Evengård B; Sandstedt K; Bölske G; Feinstein R; Riesenfelt-Orn I; Smith CI
    Clin Exp Immunol; 1994 Dec; 98(3):388-94. PubMed ID: 7994902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression of tumor necrosis factor alpha and interferon gamma in the lungs of Mycoplasma pulmonis-infected mice.
    Nishimoto M; Akashi A; Kuwano K; Tseng CC; Ohizumi K; Arai S
    Microbiol Immunol; 1994; 38(5):345-52. PubMed ID: 7935058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis.
    Lai WC; Pakes SP; Ren K; Lu YS; Bennett M
    J Immunol; 1997 Mar; 158(6):2513-6. PubMed ID: 9058780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arthritis of mice induced by Mycoplasma pulmonis: humoral antibody and lymphocyte responses of CBA mice.
    Cole BC; Golightly-Rowland L; Ward JR
    Infect Immun; 1975 Nov; 12(5):1083-92. PubMed ID: 1193724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycoplasma pulmonis V-1 surface protein variation: occurrence in vivo and association with lung lesions.
    Talkington DF; Fallon MT; Watson HL; Thorp RK; Cassell GH
    Microb Pathog; 1989 Dec; 7(6):429-36. PubMed ID: 2622331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease.
    Hodge LM; Simecka JW
    J Infect Dis; 2002 Jul; 186(2):290-4. PubMed ID: 12134269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated and humoral immune response to non-viable Mycoplasma pulmonis in mice enhanced by cross-linked ricin.
    Kishima M; Kuniyasu C; Eguchi M; Yamamoto M; Imamura E
    Vet Microbiol; 1987 Jun; 14(2):145-56. PubMed ID: 3660582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of hydrogen peroxide production by Mycoplasma pulmonis to virulence for catalase-deficient mice.
    Brennan PC; Feinstein RN
    J Bacteriol; 1969 Jun; 98(3):1036-40. PubMed ID: 5788695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract.
    Lindsey JR; Cassell H
    Am J Pathol; 1973 Jul; 72(1):63-90. PubMed ID: 4719529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection.
    Hsu HC; Zhang HG; Song GG; Xie J; Liu D; Yang PA; Fleck M; Wintersberger W; Zhou T; Edwards CK; Mountz JD
    Arthritis Rheum; 2001 Sep; 44(9):2146-59. PubMed ID: 11592380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modification of the teratogenesis of actinomycin D and cyclophosphamide by a Mycoplasma pulmonis infection in rats].
    Juhr NC; Ratsch H
    Z Versuchstierkd; 1990; 33(6):265-70. PubMed ID: 2150578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in virulence for mice among strains of Mycoplasma pulmonis.
    Davidson MK; Lindsey JR; Parker RF; Tully JG; Cassell GH
    Infect Immun; 1988 Aug; 56(8):2156-62. PubMed ID: 3397187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-chlamydial effect of experimental Mycoplasma pulmonis infection in the murine genital tract.
    Tuffrey MA; Furr PM; Falder P; Taylor-Robinson D
    J Med Microbiol; 1984 Jun; 17(3):357-62. PubMed ID: 6726786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.
    Cartner SC; Simecka JW; Lindsey JR; Cassell GH; Davis JK
    Infect Immun; 1995 Oct; 63(10):4138-42. PubMed ID: 7558330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.